Feature | July 14, 2011| Dave Fornell

Key Points in Carotid Stenting

Patient selection, technique, imaging and experience are required

Carotid stenting is a more complex and challenging procedure than coronaries or peripheral vessels. Carotid stenting experts have the following advice for hospitals and physicians that want to enter this market.


Patient Selection  
Patient selection is a major concern when it comes to carotid stenting.  Many trials focus on the most complex cases in some of the sickest patients, and many times these patients have several co-morbidities, said Sriram Iyer, M.D., FACC, associate chairman, Heart and Vascular Institute, Lenox Hill Hospital, N.Y.  Many times these patients also have left main coronary artery disease, aortic stenosis and renal dysfunction, among other problems. His recommendation is to keep procedures as simple as possible by using careful patient selection.  


“Avoid these complicated patients and keep it simple,” he explains. This will lead to fewer complications.
He said the most critical part of carotid cases is accessing the carotid arteries via the aortic arch. “The two important things you need are speed and minimal manipulation, because at this time you have no embolic protection,” Iyer said.  However, MRI or CT imaging plays a big role in being able to select patients who do not have heavy “popcorn” plaque in their aortic arch or heavy plaque burden and tortuous vessels leading into the carotids, which might make stenting a less attractive option because of the stroke risk.


Pre-Procedure Imaging
Ultrasound, MRI or CT imaging is needed to screen patients to see if they are good candidates for stenting. Some circumstances that might make physicians think twice about transcatheter interventions include extremely sharp bends in the vessel, which will likely cause emboli as wires are pushed through the vessel before an embolic protection device (EPD) can be deployed. EPDs are required for carotid stenting reimbursement from the Centers of Medicare and Medicaid Services (CMS).


Techniques
From his experience, Iyer offers the following helpful techniques for carotid stenting:
• Pre-dilatation of the vessel with a 2-2.5 mm coronary balloon to aid in the deployment of the EPD.
• EPDs generally do not offer complete vessel wall apposition in bends.
• Use a buddy wire to help straighten the vessel to deliver the EPD and to secure the vessel.
• Use a Judkins Right catheter to help support and enter the carotid side branch.
• If the anatomy of the occlusion is in a
bend, use an open-cell design stent because they bend easier.
• EPD dwell time should be less than seven minutes, because after that time fibrin quickly accumulates and clots the filter.
• Move the patient’s head to help rotate vessels in the neck.
• Ideal lesions to stent are those in straight segments of the vessel.


Barry Katzen, M.D., FSIR, medical director of Baptist Cardiac and Vascular Institute and clinical professor of radiology at the University of Miami School of Medicine, Miami, Fla., also suggests using Doppler ultrasound of the carotid artery to measure flow velocity prior to and following stenting.


Complications of Carotid Stenting
Carotid stenting studies between 2000 and 2008 showed major adverse coronary and cerebral events (MACCE) rates dropped from 8.3 percent down to 2.3 percent, mainly because operators became more experienced as time went on, said Daniel McCormick, D.O., director, cardiac catheterization laboratory at Hahnemann University Hospital, Philadelphia. “The second half of the CREST trial had a significant decrease in complications and that is all about the experience level of the operators improving,” McCormick said. “You really need to know when to quit when things are not going well.”


Katzen agreed, saying, “There has been a major improvement in patient outcomes in each of these trials. This is due to better techniques and increased operator experience...Stents will protect patients against stroke just as well as surgery.”
However, Katzen said operators need to be highly experienced to keep complications to a minimum. He advocates for only a limited number of operators at higher-volume facilities to serve as the carotid stenting experts.


McCormick said some of the complications operators may encounter include:
• Post stenting bradycardia/hypotension, caused by balloon pressures on carotid baroreceptors.
• Atropine-induced confusion in elderly patients, which complicates post-procedure neurological assessments.
• Cerebral hemorrhage is rare, but usually fatal. If suspected, the procedure needs to be terminated, reverse heparin and conduct an emergency CT scan.
• Carotid stent thrombosis, which can be aspirated.

Related Content

Abbott has pulled the Absorb Bioresorbable scaffold stent off the market.

The biggest cardiac technology story in September was Abbott pulled the Absorb Bioresorbable scaffold stent off the market because poor sales.

Feature | October 02, 2017
October 2, 2017 — Here is the list of the most popular articles and videos on the Diagnostic and Interventional Cardi
Biotronik Studies Demonstrate Efficacy of Minimizing Metal Burden in SFA Therapy
News | Stents Bare Metal| September 22, 2017
Physicians demonstrated that reducing metal burden in superficial femoral artery (SFA) therapy could effectively reduce...
Tryton Side Branch Stent Recognized With Premier Technology Breakthrough Award
News | Stents Bifurcation| September 21, 2017
September 21, 2017 — Cardinal Health and Tryton Medical Inc.
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Abbott will end sales of the Absorb bioresorbable stent scaffold, pulling it off the market September 14, 2017.
Feature | Stents Bioresorbable| September 08, 2017 | Dave Fornell
September 8, 2017 — Abbott Vascular has announced it will end commercial sales of its Absorb bioresorbable vascular s
Protembis Announces Successful First-in-Human Use of  ProtEmbo Cerebral Protection System in European Trial
News | Embolic Protection Devices| September 07, 2017
Protembis GmbH announced the first clinical applications of its ProtEmbo Cerebral Protection System to complement a...
Biotronik's Orsiro Drug-Eluting Stent Outperforms Xience in BIOFLOW-V Trial
News | Stents Drug Eluting| September 01, 2017
September 1, 2017 — Biotronik recently announced data from the BIOFLOW-V randomized trial comparing Orsiro and Xience
PinnacleHealth First in Pennsylvania to Implant Sentinel Cerebral Protection System
News | Embolic Protection Devices| August 23, 2017
PinnacleHealth is the first hospital in Pennsylvania and one of the first 10 in the country to introduce new technology...
Overlay Init